GlassScriptPhysician profile
Olga Chagin
NPI 1720509466
$1,002.66
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $604 · 2020: $206 · 2022: $68.29 · 2023: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $124.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $175.82 | 2019-2022 | |
| Organogenesis INC. | $172.31 | 2019-2020 | |
| Allergan, INC. | $125.00 | 2019 | |
| Kci USA, INC. | $121.43 | 2019 | |
| Baxter Healthcare | $87.74 | 2019 | |
| Celularity INC. | $77.00 | 2019 | |
| Averitas Pharma INC. | $63.52 | 2023 | Qutenza |
| Nevro Corp. | $61.17 | 2023 | Senza |
| Osteomed LLC | $45.23 | 2020 | |
| Misonix INC | $21.08 | 2020 | |
| Integra Lifesciences Corporation | $19.31 | 2019 | |
| Depuy Synthes Sales INC. | $12.93 | 2019 | |
| Amniox Medical, INC. | $12.12 | 2019 | |
| Polarityte, INC. | $8.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olga Chagin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.